Back to Search Start Over

The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases

Authors :
Ming-Cheng Chang
Chun-Tang Chen
Ping-Fang Chiang
Ying-Cheng Chiang
Source :
Pharmaceuticals, Vol 17, Iss 3, p 307 (2024)
Publication Year :
2024
Publisher :
MDPI AG, 2024.

Abstract

Chitinase-3-like protein-1 (CHI3L1), also known as YKL40, is a glycoprotein that belongs to the chitinase protein family. It is involved in various biological functions, including cell proliferation and tissue remodeling, with inflammatory and immunomodulatory capabilities. Several studies have shown that CHI3L1(YKL40) is upregulated in various diseases, such as cancer, asthma, and inflammatory bowel disease, among others. Although the expression level of CHI3L1(YKL40) is associated with disease activity, severity, and prognosis, its potential as a therapeutic target is still under investigation. In this review, we summarize the biological functions, pathological roles, and potential clinical applications of specific inhibitors and targeted therapies related to CHI3L1(YKL40).

Details

Language :
English
ISSN :
17030307 and 14248247
Volume :
17
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Pharmaceuticals
Publication Type :
Academic Journal
Accession number :
edsdoj.20c8028e738c4310a3418a974a852248
Document Type :
article
Full Text :
https://doi.org/10.3390/ph17030307